Bienvenue sur HématoStat.net. Nous sommes le : 22, November 2024
Réf :HematoStat.net ; 1 (12) : V34
Farhad Ravandiand al. Management of adverse events in patients with acute myeloid leukemia in remission receiving oral azacitidine: experience from the phase 3 randomized QUAZAR AML-001 trial. ol Oncol. 2021 Aug 28;14(1):133. doi: 10.1186/s13045-021-01142-x.
View all posts
Save my name, email, and website in this browser for the next time I comment.
Δ